Politics
New alarm over China controlling drug supply chains
Axios·November 19, 2026·1 min read
China is intensifying efforts to control the entire drug supply chain, risking U.S. access to future lifesaving treatments, warns the National Security Commission on Emerging Biotechnology. Analysis of 57 licensing deals since 2023 shows Western drug giants redirecting capital and know-how to Chinese firms, potentially giving Beijing control over critical pharmaceutical technologies.
Read at AxiosDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.
